Viemed Healthcare (VMD) risk factors, FY2025 10-K

Risks Related to Our Industry and Business

1. 01We compete against companies that have longer operating histories and greater resources, which may result in reduced profit margins and loss of market share
2. 02Reductions in reimbursement rates may have a materially adverse impact on the profitability of our operations51% rewritten
3. 03Our reliance on only a few sources of reimbursement for our services could result in delays in reimbursement, which could adversely affect cash flow and revenues
4. 04A reduction or elimination of coverage or reimbursement of our products by third-party payors, including Medicare, in the future could adversely affect our business and results of operationsNew
5. 05Our dependence on key suppliers puts us at risk of interruptions in the availability of the equipment we need for our services, which could reduce our revenue and adversely affect our results of operations73% rewritten
6. 06We conduct all of our operations through our United States subsidiaries and our ability to extract value from these subsidiaries may be limited
7. 07The failure to attract or to retain management or key operating personnel, including directors, could adversely affect operations
8. 08We have significant ongoing capital expenditure requirements. If we are unable to obtain necessary capital on favorable terms or at all, we may not be able to execute on our business plans and our business, financial condition, results of operations, cash flows and prospects may be adversely affected
9. 09We are subject to the risks of litigation and governmental proceedings, which could adversely affect our business
10. 10Insurance and claims expenses could significantly reduce our profitability
11. 11We rely significantly on information technology and any failure, inadequacy, interruption or security lapse of that technology, including any cybersecurity incidents, could harm our ability to operate our business effectively
12. 12The integration of artificial intelligence (AI) technologies may introduce operational risks and challenges
13. 13Disruptions in the credit and financial markets may have an adverse impact on our ability to obtain capital and financing for our operations
14. 14Our strategic growth plan, which involves the acquisition of other businesses, may not succeed
15. 15Adverse global macroeconomic conditions, including supply chain disruptions, tariffs, and fluctuations in foreign currency exchange rates, could negatively impact our operations, costs, and profitabilityNew

Risks Relating to Government Regulation

1. 16Healthcare reform legislation and/or executive action may affect our business65% rewritten
2. 17We are subject to extensive federal and state regulation, and if we fail to comply with applicable regulations, we could suffer severe criminal or civil sanctions or be required to make significant changes to our operations that could adversely affect our business, financial condition and operating results
3. 18We expect the federal and state governments to continue their efforts to contain growth in Medicaid expenditures, which could adversely affect our revenue and profitability
4. 19Revenue we receive from third-party payors as well as Medicare and Medicaid is subject to potential retroactive reduction
5. 20As a result of post-payment reviews of claims we submit to Medicare and Medicaid for our services, we may incur additional costs and may be required to repay amounts already paid to us22% rewritten
6. 21An economic downturn, state budget pressures, sustained unemployment and continued deficit spending by the federal government may result in a reduction in reimbursement and covered services
7. 22Delays in reimbursement due to claims submission reimbursement processes may cause liquidity problems24% rewritten
8. 23We depend in part upon reimbursement by third-party payors35% rewritten
9. 24We face inspections, reviews, audits and investigations under federal and state government programs and contracts. These audits could have adverse findings that may negatively affect our business
10. 25We are subject to extensive federal and state laws and regulations relating to the privacy and security of protected health information and failure to comply with such laws may increase our operational costs
11. 26The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 required the HHS to establish and implement programs under which competitive acquisition areas are established throughout the United States for purposes of awarding contracts for the furnishing of competitively priced items of DME74% rewritten
12. 27CMS actions to impose temporary enrollment moratoria and heightened screening for certain DMEPOS supplier types could limit our ability to expand, pursue acquisitions, or maintain expected operational flexibility and could increase our compliance costsNew
13. 28If CMS requires prior authorization for our products, our revenue and cash flow could be negatively impacted95% rewritten
14. 29If we fail to comply with state and federal fraud and abuse laws, including anti-kickback laws, false claims acts, self-referral prohibitions, and anti-inducement laws, we could face substantial penalties and our business, operations and financial condition could be adversely affected79% rewritten
15. 30applicable safe harbors, we cannot assure you that a government regulator will not take the position that some of our practices do not meet all of the narrow criteria of an applicable safe harbor and otherwise violate the Anti-Kickback StatuteNew
16. 31The implementation of alternative payment models and the transition of Medicaid and Medicare beneficiaries to managed care organizations may limit our market share and could adversely affect our revenues88% rewritten
17. 32not be able to gain access into certain ACOs. If we are not included in these programs, or if ACOs establish programs that overlap with our services, we could experience an adverse effect on our operations and financial conditionNew

Risks Related to our Common Shares

1. 33If we fail to establish and maintain proper disclosure controls and procedures or internal control over financial reporting, our ability to produce accurate financial statements and supplemental information, or comply with applicable regulations could be impaired
2. 34As we grow, we may be subject to growth-related risks including capacity constraints and pressure on our internal systems and controls. Our ability to manage growth effectively will require us to continue to implement and improve our operational and financial systems and to expend, train and manage our employee base
3. 35The market price for our common shares may experience substantial volatility for reasons unrelated to our financial performance. This volatility may impact the price at which shareholders can sell their common shares
4. 36The failure of our common shares to be included in various stock indices could result in the market for our common shares to become limited and volatile and the price at which you can sell your shares to decrease
5. 37Future sales of our common shares in the public market could reduce our share price, and any additional capital raised by us through the sale of equity or convertible securities may dilute the ownership of existing shareholders
6. 38We will incur increased costs as a result of operating as a U.S. public reporting company, and our management is required to devote substantial time to new compliance initiatives
7. 39Because we have no current plans to pay cash dividends on our common shares, investors may not receive any return on their investment unless the value of our common shares appreciates
8. 40Canadian laws differ from the laws in effect in the United States and may afford less protection to holders of our securities22% rewritten
9. 41of the price of our common shares and could diminish our cash reservesNew